0001213900-23-004230.txt : 20230120 0001213900-23-004230.hdr.sgml : 20230120 20230120201140 ACCESSION NUMBER: 0001213900-23-004230 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mikhak Zamaneh CENTRAL INDEX KEY: 0001962453 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 23542310 MAIL ADDRESS: STREET 1: 1751 RIVER RUN, SUITE 400 STREET 2: C/O TFF PHARMACEUTICALS, INC. CITY: FORT WORTH STATE: TX ZIP: 76107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 3 1 ownership.xml X0206 3 2023-01-05 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001962453 Mikhak Zamaneh 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 0.97 2032-12-21 Common Stock 430000 D The Options shall vest and first become exercisable as follows: one quarter of the Options shall vest and first become exercisable on December 21, 2023, and the remainder of the Options shall vest and first become exercisable in 12 equal quarterly installments commencing on March 31, 2024. /s/ Zamaneh Mikhak 2023-01-20